Excessive obesity is a global health issue. Our project focuses on early detection of obesity-related metabolic syndrome, achieving convenient and fast diagnosis through the detection of microRNA, which serves as an indicative factor.
        Scientifically speaking, our project is essentially a nucleic acid testing method that allows for progressive amplification of trace amounts of nucleic acid input signals, ultimately providing quantitative results through a visualized system. In terms of social welfare, our project meets the current demand for a healthier lifestyle. It enables individuals to perform self-tests at home, eliminating the need for complex medical examinations. Through a visualized app, people can gain a more intuitive understanding of disease-related risks and receive personalized recommendations. In the practice and promotion of synthetic biology concepts, our team has conducted multiple rounds of iterative upgrades using engineering principles. We have also organized numerous offline and online events to introduce our project and the underlying biological knowledge to people from various backgrounds. In terms of innovation and entrepreneurship, our team has had fruitful exchanges with clinical doctors and biotech companies. They are optimistic about the promotion and application prospects of our metabolic disease testing kit.
        In conclusion, our project aims to address the risks that may exist among individuals with excessive obesity. Our team advocates for a healthier and more reasonable lifestyle, and is dedicated to the early diagnosis and treatment of metabolic syndrome.